Shed and LTR Pharma Execute Definitive Commercial Agreement to Bring ROXUS® to Patients Across the United States
Salt Lake City
•
July 21, 2026
•
0 Views
SALT LAKE CITY, July 21, 2026 /PRNewswire/ -- Shed has announced the execution of a definitive commercial agreement with LTR Pharma, formalizing the companies' partnership to commercialize ROXUS®, LTR Pharma's rapid-onset intranasal treatment for erectile dysfunction, across the United States.…
Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



